The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
The latest report by IMARC, titled “ OrganPreservationMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecast20 23-2028
” " the global organ preservation market reached a value of US$ 176.4 Million in 2022.
Organ preservation refers to the method of conserving healthy organs to be further utilized for organ transplantation. It is an essential technique that helps in maintaining the functioning of tissues and organs so that the graft can function at re-perfusion. Some of the common preservation techniques include hypothermic machine perfusion, static cold storage, and normothermic machine perfusion.
These methods aid in providing sufficient oxygen and nutrition that help in reducing the chances of post-transplantation infections. Along with this, it also aids in improving the survival rates and morbidity among patients after the transplantation.
Request Free Sample Report: https://www.imarcgroup.com/organ-preservation-market/requestsample
The global market is primarily driven by the rising incidences of organ failure among the masses. This is supported by the increasing prevalence of chronic illnesses among individuals, along with the growing geriatric population. Moreover, significant investments by private and public firms to upgrade the existing healthcare infrastructure is favorably impacting the market. In line with this, the widespread utilization of preservation methods for conducting experimental studies and clinical trials in medical institutes is creating a positive market outlook. Additionally, continuous technological advancements in organ preservation techniques are acting as major growth-inducing factors.
Furthermore, numerous initiatives are undertaken by government and non-governmental organizations (NGOs) of multiple countries for encouraging organ donation activities are providing a boost to the market. Other factors, including continual improvements in the healthcare infrastructure, the acceptance of transplantation procedures, inflating disposable income levels of the masses, and extensive research and development (R&D) activities conducted by key players for introducing improved preservation methods, are also positively influencing the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 260.3 Million by 2028, growing at a CAGR of 6.5% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).
MarketSummary: BreakupbyPreservationSolution:
• UW Solution
• Custodiol HTK
• Perfadex
• Others
BreakupbyOrganDonationType:
• Living Organ Donation
• Deceased Organ Donation
BreakupbyTechnique:
• Static Cold Storage Technique
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Others
BreakupbyOrganType:
• Kidney
• Liver
• Lung
• Heart
• Others
BreakupbyEnd-User:
• Hospitals and Clinics
• Organ Banks
• Others
BreakupbyRegion:
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
CompetitiveLandscapewithKeyPlayers:
• 21st Century Medicine
• Biolife Solutions
• Bridge to Life Ltd.
• Bristol-Myers Squibb
• Dr. Franz Köhler Chemie GmbH
• Essential Pharmaceuticals.
• Lifeline Scientific
• OrganOx
• Paragonix Technologies
• TransMedics
• Waters Medical Systems
• Xvivo Perfusion
ViewFullReportwithTOC&ListofFigure:https://www.imarcgroup.com/organ-preservation-market
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
